Premium
Healthcare-focussed private equity firm InvAscent has expanded the scope of discussions to sell its stake in a vitamin manufacturing company that it had backed four years ago, people familiar with the development told VCCircle. InvAscent is looking to exit Synergia Life Sciences Pvt. Ltd and has engaged investment bank Rothschild & ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
